XBiotech Announces Payment of Dividend to Holders of Common Stock
30 juil. 2021 11h03 HE
|
XBiotech Inc.
AUSTIN, Texas, July 30, 2021 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) (“XBiotech”) has completed payment to holders of its Common Stock of a previously announced dividend in the amount of...
2021 Outlook on Decentralized Clinical Trials - Cloud-based Platform to Achieve Scalability and Workflow Standardization Presents Opportunities
26 juil. 2021 06h23 HE
|
Research and Markets
Dublin, July 26, 2021 (GLOBE NEWSWIRE) -- The "Global Decentralized Clinical Trial (DCT) Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. The report presents...
Global Clinical Trial Market (2020 to 2026) - Featuring ICON, Wuxi AppTec and SGS Among Others
22 juil. 2021 08h03 HE
|
Research and Markets
Dublin, July 22, 2021 (GLOBE NEWSWIRE) -- The "Clinical Trial Market, Global Forecast Impact of COVID-19, Industry Trends by Phases, Study Design, Region, Opportunity Company Overview, Revenue"...
Ivy Brain Tumor Center Announces Plan to Build New Global Headquarters in Phoenix
21 juil. 2021 05h00 HE
|
Ivy Brain Tumor Center
Phoenix, AZ, July 21, 2021 (GLOBE NEWSWIRE) -- The Ivy Brain Tumor Center at Barrow Neurological Institute, the largest Phase 0 clinical trials program for aggressive brain tumors, announced its...
Fluidigm Announces Conference Call and Webcast of Second Quarter 2021 Financial Results
08 juil. 2021 16h01 HE
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., July 08, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
XBiotech Announces Dividend to Holders of Common Stock
06 juil. 2021 16h30 HE
|
XBiotech Inc.
AUSTIN, Texas, July 06, 2021 (GLOBE NEWSWIRE) -- XBiotech Inc.’s (NASDAQ: XBIT) (“XBiotech”) Board of Directors has declared an extraordinary cash dividend of approximately $2.50 per share, or up to...
XBiotech Announces Receipt of $75 Million from Sale of Antibody
30 juin 2021 11h46 HE
|
XBiotech Inc.
AUSTIN, Texas, June 30, 2021 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ: XBIT) announced today it received $75 million from funds escrowed as part of its December 2019 sale of bermekimab. The True Human™...
vTv Therapeutics to Participate at the 6th World Psoriasis & Psoriatic Arthritis Conference with Poster Presentation on HPP737
29 juin 2021 07h30 HE
|
vTv Therapeutics Inc.
HIGH POINT, N.C., June 29, 2021 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT) a clinical-stage biopharmaceutical company focused on the development of orally administered treatments for...
XBiotech Announces First Patient Enrolled in Clinical Trial Evaluating XB2001 for the Treatment of Pancreatic Cancer
23 juin 2021 08h30 HE
|
XBiotech Inc.
AUSTIN, Texas, June 23, 2021 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) has enrolled the first patient in its 1-BETTER study, a randomized, double-blind, placebo-controlled clinical study to...
Global Contract Research Organization Market Report 2021
15 juin 2021 06h24 HE
|
Research and Markets
Dublin, June 15, 2021 (GLOBE NEWSWIRE) -- The "Global Contract Research Organization Market, By Service (Clinical Research Services, Early Phase Development Services, Laboratory Services, Consulting...